Реваскуляризация миокарда методом чрескожного коронарного вмешательства при хронических окклюзиях коронарных артерий у пациентов старческой возрастной группы: современный взгляд на проблему

За последние несколько десятилетий проблема ишемической болезни сердца ввиду хронической окклюзии коронарных артерий (ХОКА) у людей старческого возраста выходит на передний план. Причина тому, отсутствие общепринятых стратегий лечения данных групп больных. Выбор метода реваскуляризации миокарда у людей старческого возраста оказывает основополагающее влияние на клинические результаты, но требует дополнительных исследований. Нет сомнений, что чрескожное коронарное вмешательство (ЧКВ) при ХОКА за последние годы приобретает весомый статус как метод первого выбора при лечении данной патологии. Основные причины: развитие методов внутрисосудистой визуализации, совершенствование хирургического инструментария, разработка новейших подходов и тактик реканализации, рост опыта хирургов. Применение ЧКВ при ХОКА у старческой возрастной группы продиктовано тенденциями к увеличению доли старческого населения во всех регионах планеты. Данный обзор рассматривает обоснованность и возможность применения ЧКВ при ХОКА у пациентов старческого возраста, его безопасность, преимущества и перспективы. Поиск статей для написания данного обзора осуществлялся с помощью баз данных Medline (PubMed), РИНЦ (eLIBRARY), Google Scholar.

1. Nowbar AN, Gitto M, Howard JP, et al. Mortality From Ischemic Heart Disease. Circ Cardiovasc Qual Outcomes. 2019;12(6):e005375. doi:10.1161/CIRCOUTCOMES.118.005375.

2. World Health Organization. Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2016; 2018. https://www.who.int/healthinfo/global_burden_disease/estimates/en/index1.html.

3. Cosco TD, Howse K, Brayne C. Healthy ageing, resilience and wellbeing. Epidemiol Psychiatr Sci. 2017;26(6):579-83. doi:10.1017/S2045796017000324.

4. England K, Azzopardi-Muscat N. Demographic trends and public health in Europe. Eur J Public Health. 2017;27(suppl_4):9-13. doi:10.1093/eurpub/ckx159.

5. Kim JY, Jeong MH, Choi YW, et al. Korea Acute Myocardial Infarction Registry Investigators. Temporal trends and in‐hospital outcomes of primary percutaneous coronary intervention in nonagenarians with ST‐segment elevation myocardial infarction. Korean J Intern Med. 2015;30:821-8. doi:10.3904/kjim.2015.30.6.821.

6. Mizuguchi Y, Hashimoto S, Yamada T, et al. Percutaneous coronary intervention for nonagenarian patients with ST‐segment elevation myocardial infarction: experience of a single Japanese center. J Cardiol. 2016;67:331-4. doi:10.1016/j.jjcc.2015.12.002.

7. Gayed M, Yadak N, Qamhia W, et al. Comorbidities and complications in nonagenarians undergoing coronary angiography and intervention. Int Heart J. 2017;58:180-4. doi:10.1536/ihj.16-083.

8. Numasawa Y, Inohara T, Ishii H, et al. J‐PCI Registry Investigators Comparison of Outcomes After Percutaneous Coronary Intervention in Elderly Patients, Including 10 628 Nonagenarians: Insights From a Japanese Nationwide Registry (J-PCI Registry). J Am Heart Assoc. 2019;8(5):e011183. doi:10.1161/JAHA.118.011017.

9. Helft G, Georges J-L, Mouranche X, et al. Outcomes of primary percutaneous coronary interventions in nonagenarians with acute myocardial infarction. Int J Cardiol. 2015;192:249. doi:10.1016/j.ijcard.2015.04.227.

10. Sawant AC, Josey K, Plomondon ME, et al. Temporal Trends, Complications, and Predictors of Outcomes Among Nonagenarians Undergoing Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. JACC Cardiovasc Interv. 2017;10(13):1295-303. doi:10.1016/j.jcin.2017.03.051.

11. Su YM, Pan M, Geng H-H, et al. Outcomes after percutaneous coronary intervention and comparison among scoring systems in predicting procedural success in elderly patients (≥ 75 years) with chronic total occlusion. Coron Artery Dis. 2019;30(7):481-7. doi:10.1097/MCA.0000000000000765.

12. Lee SH, Yang JH, Choi S-H, et al. Long-Term Clinical Outcomes of Medical Therapy for Coronary Chronic Total Occlusions in Elderly Patients (≥75 Years). Circ J. 2015;79(8):17806. doi:10.1253/circj.CJ-15-0041.

13. Flores-Umanzor EJ, Vázquez S, Cepas-Guillen P, et al. Impact of revascularization versus medical therapy alone for chronic total occlusion management in older patients. Catheter Cardiovasc Interv. 2019;94(4):527-35. doi:10.1002/ccd.28163.

14. Hoebers LP, Claessen BE, Elias J, et al. Meta-analysis on the impact of percutaneous coronary intervention of chronic total occlusions on left ventricular function and clinical outcome. Int J Cardiol. 2015;187:90-6. doi:10.1016/j.ijcard.2015.03.164.

15. Guo L, Lv H, Zhonget L, et al. Comparison of long-term outcomes of medical therapy and successful recanalisation for coronary chronic total occlusions in elderly patients: a report of 1,294 patients. Cardiovasc Diagn Ther. 2019;9(6):586-95. doi:10.21037/cdt.2019.11.01.

16. Kassimis G, Karamasis GV, Katsikis A, et al. Should Percutaneous Coronary Intervention be the Standard Treatment Strategy for Significant Coronary Artery Disease in all Octogenarians? Curr Cardiol Rev. 2021;17(3):244-59. doi:10.2174/1573403X16666200903153823.

17. Gu D, Qu J, Zhang H, Zheng Z. Revascularization for Coronary Artery Disease: Principle and Challenges. Adv Exp Med Biol. 2020;1177:75-100. doi:10.1007/978-981-15-2517-9_3.

18. Doenst T, Haverich A, Serruys P, et al. PCI and CABG for Treating Stable Coronary Artery Disease: JACC Review Topic of the Week. J Am Coll Cardiol. 2019;73(8):964-76. doi:10.1016/j.jacc.2018.11.053.

19. Lee S-W, Lee PH, Ahn J-M, et al. Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion. Circulation. 2019;139(14):167483. doi:10.1161/CIRCULATIONAHA.118.031313.

20. Thuijs DJFM, Kappetein AP, Serruys PW, et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. Lancet. 2019;394(10206):1325-34. doi:10.1016/S0140-6736(19)31997-X.

21. Gimbel ME, Willemsen LM, Daggelders MC, et al. Long-term follow-up after bypass surgery or coronary stenting in elderly with multivessel disease. Neth Heart J. 2020;28(9):467-77. doi:10.1007/s12471-020-01415-z.

22. Stone GW, Kappetein AP, Sabik JF, et al. EXCEL Trial. Investigators Five-Year Outcomes after PCI or CABG for Left Main Coronary Disease. N Engl J Med. 2019;381(19):1820-30. doi:10.1056/NEJMoa1909406.

23. Rai P, Taylor R, Bittar NM. Long-term survival in patients who had CABG with or without prior coronary artery stenting. Open Heart. 2020;7(2):e001160. doi:10.1136/openhrt-2019-001160.

24. Moussa ID, Mohananey D, Saucedo J, et al. Trends and Outcomes of Restenosis After Coronary Stent Implantation in the United States. J Am Coll Cardiol. 2020;76(13):1521-31. doi:10.1016/j.jacc.2020.08.002.

25. Pleva L, Kukla P, Hlinomaz O. Treatment of coronary in-stent restenosis: a systematic review. J Geriatr Cardiol. 2018;15(2):173-84. doi:10.11909/j.issn.1671-5411.2018.02.007.

26. Mavroudis CA, Kotecha T, Chehab O, et al. Superior long term outcome associated with native vessel versus graft vessel PCI following secondary PCI in patients with prior CABG. Int J Cardiol. 2017;228:563-9. doi:10.1016/j.ijcard.2016.11.031.

27. Giustino G, Mehran R, Serruys PW, et al. Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial. J Am Coll Cardiol. 2018;72(7):754-65. doi:10.1016/j.jacc.2018.05.057.

28. Toma A, Gebhard C, Gick M, et al. Survival after percutaneous coronary intervention for chronic total occlusion in elderly patients. Euro Intervention. 2017;13(2):e228-e235. doi:10.4244/EIJ-D-16-00499.

29. Fefer P, Knudtson ML, Cheema AN, et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol. 2012;59(11):991-7. doi:10.1016/j.jacc.2011.12.007.

30. Habib GB, Heibig J, Forman SA, et al. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation. 1991;83(3):739-46. doi:10.1161/01.cir.83.3.739.

31. Azzalini L, Dautov R, Ojeda S, et al. Procedural and long-term outcomes of percutaneous coronary intervention for in-stent chronic total occlusion. JACC Cardiovasc Interv. 2017;10(9):892-902. doi:10.1016/j.jcin.2017.01.047.

32. Tomasello SD, Boukhris M, Giubilato S, et al. Management strategies in patients affected by chronic total occlusions: results from the Italian Registry of Chronic Total Occlusions. Eur Heart J. 2015;36(45):3189-98. doi:10.1093/eurheartj/ehv450.

33. Stuijfzand WJ, Driessen RS, Raijmakers PG, et al. Prevalence of ischaemia in patients with a chronic total occlusion and preserved left ventricular ejection fraction. Eur Heart J Cardiovasc Imaging. 2017;18(9):1025-33. doi:10.1093/ehjci/jew188.

34. Hannan EL, Zhong Y, Berger PB, et al. Comparison of intermediate-term outcomes of coronary artery bypass grafting versus drug-eluting stents for patients ≥75 years of age. Am J Cardiol. 2014;113(5):803-8. doi:10.1016/j.amjcard.2013.11.035.

35. Henriques JP, Hoebers LP, Ramunddal T et al. Percutaneous intervention for concurrent chronic total occlusions in patients with STEMI: the EXPLORE trial. J Am Coll Cardiol. 2016;68(15):1622-32. doi:10.1016/j.jacc.2016.07.744.

36. Elias J, van Dongen IM, Hoebers LP, et al. Improved recovery of regional left ventricular function after PCI of chronic total occlusion in STEMI patients: a cardiovascular magnetic resonance study of the randomized controlled EXPLORE trial. J Cardiovasc Magn Reson. 2017;19(1):53. doi:10.1186/s12968-017-0369-z.

37. Pinto G, Fragasso G, Gemma M, et al. Long-term clinical effects of recanalization of chronic coronary total occlusions in patients with left ventricular systolic dysfunction. Catheter Cardiovasc Interv. 2020;96(4):831-8. doi:10.1002/ccd.28850.

38. Valenti R, Migliorini A, De Gregorio MG, et al. Impact of complete percutaneous revascularization in elderly patients with chronic total occlusion. Catheter Cardiovasc Interv. 2020;95(1):145-53. doi:10.1002/ccd.28452.

39. Zhang HP, Ai H, Zhao Y, et al. Effect of Chronic Total Occlusion Percutaneous Coronary Intervention on Clinical Outcomes in Elderly Patients. Am J Med Sci. 2018;355(2):174-82. doi:10.1016/j.amjms.2017.09.007.

40. Conrotto F, Scacciatella P, D’Ascenzo F, et al. Long-term outcomes of percutaneous coronary interventions or coronary artery bypass grafting for left main coronary artery disease in octogenarians (from a Drug-Eluting stent for LefT main Artery registry substudy). Am J Cardiol. 2014;113(12):2007-12. doi:10.1016/j.amjcard.2014.03.044.

41. Blokzijl F, van der Horst IC, Keus E, et al. Quality of life in elder adults one-year after coronary bypass. J Vasc Nurs. 2016;34(4):152-7. doi:10.1016/j.jvn.2016.07.002.

42. Nicolini F, Contini GA, Fortuna D, et al. Coronary artery surgery versus percutaneous coronary intervention in octogenarians: long-term results. Ann Thorac Surg. 2015;99(2):567-74. doi:10.1016/j.athoracsur.2014.09.019.

43. Guo L, Lv H, Huang R-C. Percutaneous Coronary Intervention in Elderly Patients with Coronary Chronic Total Occlusions: Current Evidence and Future Perspectives. Clin Interv Aging. 2020;15:771-81. doi:10.2147/CIA.S252318.